Anti-tumor properties of blackseed (Nigella sativa L.) extracts

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 6, 2007, Pages 839-847

  Mbarek, L Ait ^a   Mouse, H Ait ^a   Elabbadi, N ^a   Bensalah, M ^a   Gamouh, A ^a   Aboufatima, R ^b   Benharref, A ^b   Chait, A ^b   Kamal, M ^a   Dalal, A ^b   Zyad, A ^a  

^a FACULTÉ DES SCIENCES ET TECHNIQUES GUÉLIZ   (Morocco)

^b FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

Author keywords

Anti tumor activity; Cytotoxicity; Extracts; Nigella sativa L.

Indexed keywords

ACETIC ACID ETHYL ESTER; BUTANOL; DOXORUBICIN; ESSENTIAL OIL; NIGELLA SATIVA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; LIVER METASTASIS; MOUSE; NONHUMAN; SOLID TUMOR; TUMOR CELL; TUMOR VOLUME; VERO CELL;

ANIMALIA; NIGELLA SATIVA;

EID: 34347325012     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2006005000108     Document Type: Article

References (28)

1. Suffness M, Douras J. Methods in drugs development. De Vita Jr and Busch H (Editors), Drugs of plant origin. New York: Academic Press; 1982.
2. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi: Council of Scientific and Industrial Research; 1956.
3. Nadkami K. Crocus sativus, Nigella sativa. In: Nadkami KM (Editor), Indian materia medica. Bombay: Popular Prakashan; 1976. p 386-411.
4. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res 1998; 18: 1527-1532.
5. Medinica R, Mukerjee S, Huschart T, Corbitt W. Immunomodulatory and anticancer activity of Nigella sativa plant extract in humans. Proceedings of the American Association for Cancer Research Annual Meeting. 1994. p A2865.
6. Mahfouz M, Abdel-maguid R, El-Dakhakhny M. The effect of nigellon therapy on the histaminopexic power of blood sera asthmatic patients. Arzneimittelforschung 1965; 15:1230-1231.
7. Al-Hader A, Aqel M, Hassan Z. Hypoglycaemic effects of the volatile oil of Nigella sativa. Int J Pharmacognosy 1993; 31: 96-100.
8. El Tahir KE, Ashour MM, al-Harbi MM. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 1993; 24:1123-1131.
9. Houghton PJ, Zarka R, de las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995; 61: 33-36.
10. El-Alfy T, El-Fatatry H, Toama M. Isolation and structure assignment of an anti-microbial principle from the volatile oil Nigella sativa L. Pharmazia 1975; 30:109-111.
11. Mahfouz M, El-Dakhakhny M. The isolation of a crystalline active principle from Nigella sativa seeds. Pharm Sci United Arab Rep 1960; 1: 19.
12. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305.
13. Salomi NJ, Nair SC, Jayawardhanan KK, Varghese CD, Panikkar KR. Antitumour principles from Nigella sativa seeds. Cancer Lett 1992; 63: 41-46.
14. Salomi MJ, Nair SC, Panikkar KR. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical caminogenesis in mice. Nutr Cancer 1991; 16: 67-72.
15. Swamy SMK, Tan BKH. Extraction, isolation and characterization of anti-tumor principle, alpha-Hederin, from the seeds of Nigella sativa Planta Medica 2001; 67: 29-32.
16. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, et al. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol 2004; 25: 857-866.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
18. Zyad A, Branellec D, Mahe Y, Tursz T, Chouaib S. The development of human tumor-cell resistance to TNF-alpha does not confer resistance to cytokine-induced cellular cytotoxic mechanisms. Int J Cancer 1992; 52: 953-958.
19. Zyad A, Benard J, Tursz T, Clarke R, Chouaib S. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res 1994; 54: 825-831.
20. Zyad A, Cai Z, Modzet J, Legres LG, Benard J, Chouaib S. In vivo effect of the combination of TNF and adriamycin against a human breast cell line expressing the MDR-phenotype. Int J Oncol 1995; 7: 1067.
21. Yoshikawa T, Kokura S, Tainaka K, Naito Y, Kondo M. A novel cancer therapy based on oxygen radicals. Cancer Res 1995; 55: 1617-1620.
22. Swamy SM, Tan BK. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J Ethnopharmacol 2000; 70:1-7.
23. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J 2000; 350 (Part 3): 757-763.
24. Zhang S, Won YK, Ong CN, Shen HM. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents 2005; 5: 239-249.
25. Rafi MM, Bai NS, Chi TH, Rosen RT, White E, Perez D, et al. A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylation. Anticancer Res 2005; 25: 313-318.
26. Fukuyama Y, Minoshima Y, Kishimoto Y, Chen IS, Takahashi H, Esumi T. Iddoid glucosides and p-coumaroyl iridoids from Vibumum luzonicum and their cytotoxicity. J Nat Prod 2004; 67:1833-1838.
27. Badary OA, Gamal El-Din AM. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev 2001; 25: 362-368.
28. Badary OA. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J Ethnopharmacol 1999; 67: 135-142.